A. Originalarbeiten
1. A. Geier, D. Bergemann, L. von Meyer: Evaluation of a solid phase extraction procedure for the simultaneous determination of morphine, 6-monoacetylmorphine, codeine and dihydrocodeine in plasma and whole blood by GC/MS. Int J Legal Med 1996, 109: 80-83. IF 1,6
2. D. Bergemann, A. Geier, L von Meyer: Determination of lysergic acid diethylamide in body fluids by high-performance liquid chromatography and fluorescence detection. Forensic Science Int 1999, 44(2): 372-374. IF 1,5
3. T. Gerloff, A. Geier, B. Stieger, B. Hagenbuch, P.J. Meier, S. Matern, C. Gartung: Differential expression of basolateral and canalicular organic anion transporters during regeneration of rat liver. Gastroenterology 1999, 117:1408-1515. IF 11,3
4. A. Geier, C.G. Dietrich, F. Lammert, T. Orth, W.J. Mayet, S. Matern, C. Gartung: Regulation of organic anion transporters in a new rat model of acute and chronic cholangitis resembling human primary sclerosing cholangitis. J Hepatology 2002, 36(6):718-724. IF 4,8
5. A. Geier, S.K. Kim, F. Lammert, T. Gerloff, C.G. Dietrich, S.J. Karpen, B. Stieger, P.J. Meier, S. Matern, C. Gartung: Selective down-regulation of basolateral organic anion transporters in a rat liver model of acute toxic liver injury induced by carbon tetrachloride. J Hepatology 2002, 37: 198-205. IF 4,8
6. T. Gerloff, A. Geier, I. Roots, P.J. Meier, C. Gartung: Functional analysis of the rat bile salt export pump gene promotor. Eur J Biochemistry 2002, 269: 3495-3503. IF 2,8
7. E. Purucker, H.U. Marschall, A. Geier, C. Gartung, S. Matern: Increase in renal glutathione in cholestatic liver disease is due to a direct effect of bile acids. Am J Physiology 2002, 283: F1281-1289. IF 4,5
8. R. Schiffer, M. Neis,D. Höller, F. Rodriguez, A. Geier, C. Gartung, F. Lammert, A. Dreuw, G. Zwadlo-Klarwasser, H. Merk,F. Jugert,J.M. Baron: Active influx transport is mediated by members of the organic anion transporting polypeptide family in human epidermal
keratinocytes. J Invest Dermatol 2003, 120: 285-291. IF 2,8
9. A. Geier, C.G. Dietrich, T. Gerloff, J. Haendly, G.A. Kullak-Ublick, B. Stieger, P.J. Meier, S. Matern, C. Gartung: Regulation of Organic Anion Transporters in Ethinylestradiol-Induced Cholestasis in the Rat. Biochim Biophys Acta 2003, 1609: 87-94. IF 2,8
10. A. Geier, P.R. Mertens, T. Gerloff, C.G. Dietrich, A. En-Nia, G.A. Kullak-Ublick, S.J. Karpen, S. Matern, C. Gartung: Constitutive rat multidrug-resistance protein 2 gene transcription is down-regulated by Y-box protein 1. Biochem Biophys Res Commun 2003, 309: 612-8.
IF 2,8
11. A. Geier, C.G. Dietrich, S. Voigt, S. Kim, T. Gerloff, G.A. Kullak-Ublick, J. Lorenzen, S. Matern, C. Gartung: Effects of proinflammatory cytokines on rat organic anion transporters during toxic liver injury and cholestasis. Hepatology 2003, 38: 345-354. IF 9,5
12. E. Roeb, E. Purucker, C. Gartung, A. Geier, B. Jansen, R. Winograd, S. Matern: Effect of glutathione depletion and hydrophilic bile acids on hepatic acute phase reaction in rats with extrahepatic cholestasis. Scan J Gastroenterol 2003, 38: 878-885. IF 1,8
13. C.G. Dietrich*, A. Geier*, N. Salein, F. Lammert, E. Roeb, R.P. Oude Elferink, S. Matern, C. Gartung: Consequences of bile-duct obstruction on intestinal expression and function of Multidrug-resistance associated protein 2. Gastroenterology 2004, 126: 1044- 53. IF 13,1
14. F. Lammert, D.Q.H. Wang, S. Hillebrandt, A. Geier, P. Fickert, M. Trauner, B. Paigen, M.C. Carey: Spontaneous Cholecysto- and Hepatolithiasis in Mdr2-knockout Mice: A model for low phospholipid-associated cholelithiasis. Hepatology 2004, 39: 117-128. IF 10,4
15. H.E. Wasmuth, A. Werth, T. Müller, T. Berg, C.G. Dietrich, A. Geier, C. Gartung, J. Lorenzen, S. Matern, F. Lammert: Haplotype-tagging RANTES gene variants influence response to antiviral therapy in chronic hepatitis C. Hepatology 2004, 40: 327-34. IF 10,4
16. H.E. Wasmuth, A. Werth, T. Mueller, T. Berg, C.G. Dietrich, A. Geier, R. Schirin-Sokhan, C Gartung, J Lorenzen, S Matern, F Lammert: CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia. J Mol Med 2004, 82: 64-9. IF 4,3
17. A. Geier*, M. Reugels*, R. Weiskirchen, H.E. Wasmuth, C.G. Dietrich, E. Siewert, C. Gartung, J. Lorenzen, A.K. Bosserhoff, M. Brügmann, A.M. Gressner, S. Matern, F. Lammert: Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver International 2004, 24: 285-94. IF 1,8
18. E. Siewert, C.G. Dietrich, F. Lammert, P.C. Heinrich, S. Matern, C. Gartung, A. Geier: Interleukin-6 regulates hepatic transporters during acute-phase response. Biochem Biophys Res Commun 2004, 322: 232-8. IF 2,9
19. H.E. Wasmuth, C. Stolte, A. Geier, C.G. Dietrich, C. Gartung, J. Lorenzen, S. Matern, F. Lammert: The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C. BMC Infect Dis 2004, 13; 4. IF 2,1
20. C.G. Dietrich, A. Geier, H.E. Wasmuth, D.R. de Waart, R.P.J. Oude Elferink, S. Matern, C. Gartung: Influence of biliary cirrhosis on the detoxification and elimination of a food-derived carcinogen. Gut 2004, 53: 1850-5. IF 6,6
21. H.E. Wasmuth, D. Kunz, E. Yagmur, A. Timmer-Stranghoner, D. Vidacek, E. Siewert, J. Bach, A. Geier, E.A. Purucker, A.M. Gressner, S. Matern, F. Lammert: Patients with acute on chronic liver failure display ’sepsis-like‘ immune paralysis. J Hepatology 2005, 42: 195-201. IF 4,9
22. A. Geier*, G. Zollner*, C.G. Dietrich, M. Wagner, P. Fickert, H. Denk, N. van Rooijen, S. Matern, C. Gartung, M. Trauner: Cytokine-independent repression of rodent Ntcp in obstructive cholestasis. Hepatology 2005, 41: 470-7. IF 9,8
23. A. Geier, C.G. Dietrich, S. Voigt, M. Ananthanarayanan, F. Lammert, A. Schmitz, M. Trauner, H.E. Wasmuth, D. Boraschi, N. Balasubramaniyan, F.J. Suchy, S. Matern, C. Gartung: Cytokine-dependent regulation of organic anion transporters and corresponding gene transactivators in mouse liver. Am J Physiology 2005, 289 (5): G831-41. IF 3,7
24. A. Geier, C.G. Dietrich, T. Grote, U. Beuers, T. Prüfer, S. Matern, C. Gartung, A.L. Gerbes, M. Bilzer: Characterization of organic anion transporter regulation, glutathione metabolism and bile formation in the obese Zucker rat. J Hepatology 2005, 43 (6): 1021-30. IF 4,9
25. S. Hillebrandt, H.E. Wasmuth, R. Weiskirchen, C. Hellerbrand, H. Keppeler, A. Werth, R. Shirin-Sokhan, G. Wilkens, A. Geier, J. Lorenzen, J. Köhl, A.M. Gressner, S. Matern, F. Lammert: Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nature Genet 2005, 37 (8): 835-43. IF 25,8
26. G. Zollner, M. Wagner, P. Fickert, A. Geier, A. Fuchsbichler, D. Silbert, J. Gumhold, K. Zatloukal, A. Kaser,H. Tilg, H. Denk, M. Trauner: Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. Am J Physiology 2005, 289 (5): G798-805. IF 3,7
27. M. Roderfeld*, A. Geier*, C. Dietrich, E. Siewert, B. Jansen, C. Gartung, E. Roeb: Cytokine blockade inhibitis hepatic TIMP-1 expression and upregulates MMP-9 in toxix liver injury. Liver International 2006, 26 (5): 579-86. IF 2,3
28. T. Rath, M. Roderfeld, J. Graf, S. Wagner, A. Vehr, C.G. Dietrich, A. Geier, E. Roeb: Enhanced expression of matrix metalloproteinases-7 and -13 in colon mucosa of patients with inflammatory bowel disease and adenomatous polyps. Inflam Bowel Disease 2006, 12 (11): 1025-1035. IF 3,0
29. A. Geier, C.G. Dietrich, M. Trauner, C. Gartung: Extrahepatic cholestasis down-regulates Oatp1 by TNFa signalling without affecting Oatp2 and Oatp4 expression and sodium-independent bile salt uptake in rat liver. Liver International 2007, 27 (8): 1056-65. IF 2,3
30. C.G. Dietrich*, I.V. Martin*, A.C. Porn, C. Gartung, C. Trautwein, A. Geier: Fasting induces basolateral uptake transporters of the SLC family in the liver via PGC1a-mediated coactivation of HNF4a. Am J Physiology 2007, 293 (3): G585-90. IF 3,7
31. A. Geier, I.V. Martin, C.G. Dietrich, N. Balasubramaniyan, F.J. Suchy, C. Gartung,
C. Trautwein, M. Ananthanarayanan: Hepatocyte nuclear factor 4 is a central regulator of NTCP genes in rodents. Am J Physiology 2008, 295(2): G226-33. IF 3,7
32. S. Dooley, J. Hamzavi, H. Weng, L. Ciuclan, P. Godoy, I. Ilkavets, S. Ehnert, E. Ueberham, R. Gebhardt, S. Kanzler, A. Geier, K. Breitkopf, P.R. Mertens: Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage. Gastroenterology 2008, 135(2): 642-59. IF 13,1
33. J.J.W. Tischendorf, K. Wopp, K.L. Streetz, J. Bach, M. Meyer, S. Tischendorf, N. Gassler, A. Koch, A. Geier, H.E. Wasmuth, C. Trautwein, R. Winograd: The value of duodenal biopsy within routine upper endoscopy: a prospective study in 1000 patients. Z Gastroenterologie 2008, 46(8): 771-5. IF 1,0
34. C.G. Dietrich, S. Laupichler, S. Stanzel, R. Winograd, O. Al-Taie, C. Gartung, A. Geier. Origin of and therapeutic approach to cardiac syndrome X: results of the proton pump inhibitor therapy for angina-like lingering pain trial (PITFALL trial). World J Gastroenterol. 2008, 14(42): 6506-12. IF 3,3
35. R. Stienstra, F. Saudale, C. Duval, A. Geier, S. Keshtkar, J.E.M. Groener, N. van Rooijen, B. Staels, S. Kersten, M. Muller. Kupffer cells promote hepatic steatosis via interleukin-1ß-dependent suppression of peroxisome proliferator-activated receptor α activity. Hepatology 2010, 51(2): 511-522 [Correction Hepatology 2011, 53(4): 1415]. IF 10,8
36. I.V. Martin, J. Schmitt, A. Minkenberg, J.C. Mertens, B. Stieger, B. Mullhaupt, A. Geier. Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-mice. Biol Chem 2010, 391(12):1441-9. IF 2,7
37. R. Iwata, B. Stieger, J. Mertens, T. Müller, K. Baur, P. Frei, J. Braun, A. Vergopoulos, I.V. Martin, J. Schmitt, O. Goetze, S. Bibert, P.Y. Bochud, B. Müllhaupt, T. Berg, A. Geier; Swiss Hepatitis C Cohort Study Group. The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C. J Viral Hepat 2011 18(11):768-78. IF 3,3
38. R. Iwata*, K. Baur*, B. Stieger, J.C. Mertens, A.K. Daly, P. Frei, J. Braun, A. Vergopoulos, F. Stickel, K. Sabrane, I.V. Martin, J. Schmitt, O. Goetze, C.P. Day, B. Muellhaupt, A. Geier. A common polymorphism in the ABCB11 gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease. Clin Sci (Lond) 2011, 120(7):287-96. IF 4,0
39. P. Dutkowski*, C. Oberkofler*, M. Bechir, B. Müllhaupt, A. Geier, D.A. Raptis, P.-A. Clavien. The MELD Allocation System for Liver Transplantation Saves Lives, but Increases Morbidity and Cost- A prospective Outcome Analysis. Liver Transplant 2011, 17(6):674-84. IF 4,6
40. C.G. Dietrich, A.-K. Vehr, I.V. Martin, N. Gassler, T. Rath, E. Roeb, J. Schmitt, C. Trautwein, A. Geier. Downregulation of BCRP in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food-derived carcinogen. Int J Cancer 2011, 129(3):546-52. IF 4,7
41. P. Dutkowski*, C.E. Oberkofler*, K. Slankamenac, M.A. Puhan, E. Schadde, B. Müllhaupt, A. Geier, P.-A. Clavien. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the MELD Era. Ann Surg 2011, 254(5):745-53. IF 7,9.
42. J.C. Mertens*, I.V. Martin*, J. Schmitt*, P. Frei, P. Bruners, C. Herweg, A.H. Mahnken, B. Müllhaupt, A. Geier. Radiofrequency ablation in rat liver results in larger necrosis volume but activates growth signals when combined with multikinase inhibitor sorafenib. Eur J Radiology 2012, 81(7):1601-6. IF 2,6.
43. K. Baur, J.C. Mertens, J. Schmitt, R. Iwata, B. Stieger, J.J. Eloranta, P. Frei, F. Stickel, M.T. Dill, B. Seifert, H.A. Bischoff Ferrari, A. von Eckardstein, P.Y. Bochud, B. Müllhaupt, A. Geier; Swiss Hepatitis C Cohort Study Group. Combined effect of 25-OH vitamin D plasma levels and genetic Vitamin D Receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int. 2012, 32(4):635-643. IF 3,8
44. K. Baur, J. C. Mertens, J. Schmitt, R. Iwata, B. Stieger, P. Frei, B. Seifert, F. Stickel, H.A. Bischoff Ferrari, A. von Eckardstein, B. Müllhaupt, A. Geier. The Vitamin D Receptor gene bAt (CCA)-haplotype impairs the response to PEG-interferon/ribavirin based therapy in chronic hepatitis C patients. Antiviral Ther 2012, 17(3):541-7. IF 3,8
45. P. R. Mertens, I. V. Martin, B. C. Frye, T. Rauen, S. Strauch, M. Pabst, A. Geier. A biphasic response with enhanced transcription and subcellular shuttling of YB-1 to interleukin-1 beta regulates rat Mrp2 gene expression. Eur J Cell Biol 2012, 91(6-7):533-41. IF 3,6
46. J. Schmitt, M. Roderfeld, K. Sabrane, P. Zhang, Y. Tian, J.C. Mertens, P. Frei, B. Stieger, A. Weber, B. Müllhaupt, E. Roeb, A. Geier. Complement factor C5 deficiency delays the progression of biliary fibrosis in bile duct-ligated mice. Biochem Biophys Res Commun 2012 2012, 418(3):445-50. IF 2,6
47. C.M. Frei-Lanter, S.R. Vavricka, T.H.C. Kruger, R. Tutuian, A. Geier, P. Bauerfeind, T. Krones, M. Fried, P. Frei. Endoscopy for Repeatedly Ingested Sharp Foreign Bodies In Patients With Borderline Personality Disorder: An International Survey. Eur J Gastroenterol & Hepatol 2012, 24(7):793-7. IF 1,6
48. N. Many, F. Stickel, J. Schmitt, B. Stieger, M. Soyka, P. Frei, O. Götze, B. Müllhaupt, A. Geier. Genetic variations in bile acid homeostasis are not overrepresented in alcoholic cirrhosis compared to patients with heavy alcohol abuse and absent liver disease. Mutagenesis 2012, 27(5): 567-72. IF 4,0
49. C.M. Lange, S. Bibert, Z. Kutalik, K. Morikawa, A. Cerny, J.-F. Dufour, T.J. Gerlach, M.H. Heim, R. Malinverni, A. Geier, F. Negro, S. Regenass, J. Bojunga, K. Badenhoop, C. Sarrazin, S. Zeuzem, T. Berg, J. Gouttenoire, P.-Y. Bochud, D. Moradpour, Swiss Hepatitis C Cohort Study. A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C. PLoS ONE 2012, in press. IF 4,0
50. M. Rau, F. Stickel, S. Russmann, C. Manser, P. Becker, M. Weisskopf, J. Schmitt, M. Dill, J.F. Dufour, D. Moradpour, D. Semela, B. Müllhaupt, A. Geier. Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. J Hepatology 2013 (accepted). IF 9,3
51. Free fatty acids repress SHP activation and adiponectin counteracts bile acid induced liver injury in super-obese patients with NASH. L.P. Bechmann, P. Kocabayoglu, J.-P. Sowa, S. Sydor, J. Best, M. Schlattjan, A. Beilfuss, J. Schmitt, R.A. Hannivoort, A. Kilicarslan, C. Rust, F. Berr, G. Gerken, S.L. Friedman, A. Geier*, A. Canbay*. Hepatology 2013 (accepted). IF 11,7
B. Übersichtsarbeiten
1. A. Geier, C. Gartung, G. Staatz, H.N. Nguyen, S. Matern: Moderne Diagnostik benigner und maligner Raumforderungen der Leber. Dt Ärzteblatt 2001, 98: A 3120-3131.
2. H.E. Wasmuth, C. Stolte, A. Koch, A. Geier, C. Gartung, S. Matern: Ziele und Strategien der Adipositastherapie. VitaMinSpur 2000, 15: 176-179.
3. F. Lammert, A. Geier, A. Figge, S. Matern: Pathogenese der Cholezystolithiasis – neue molekulare Konzepte. Chir Gastroenterol 2001, 17: 108-113. IF 0,7
4. H. Wasmuth, C. Gartung, A. Geier, F. Lammert, S. Matern: Die glutensensitive Enteropathie (Zoeliakie, Sprue) – Aspekte der Klassifizierung, Pathogenese, Diagnostik, und Therapie. Ernährung&Medizin 2002, 17: 74-77.
5. C.G. Dietrich, A. Geier, J. Tacke, C. Gartung, S. Matern: Therapie des hepatozellulären Karzinoms. Dt. Ärzteblatt 2003, 100: A772-782.
6. A. Geier*, C. Gartung*, C.G. Dietrich, F. Lammert, H.E. Wasmuth, S. Matern: Diagnostik cholestatischer Erkrankungen. Medizinische Klinik 2003, 98: 499-509. IF 0,4
7. C.G. Dietrich, A. Geier, R.P.J. Oude Elferink, S. Matern: Defense barriers in the body: contribution of multidrug resistance-associated protein 2. Comm. Toxicol. 2003, 9: 201-14.
8. C.G. Dietrich, A. Geier, R.P. Oude Elferink: The ABC of oral bioavailability: Transporters as gatekeepers in the gut. Gut 2003, 52: 1788-1795. IF 5,9
9. A. Geier, C. Gartung, S. Matern: Regulationsmechanismen hepatobiliärer Transporter bei
cholestatischen Erkrankungen. Medizinische Klinik 2004, 99: 7-17. IF 0,5
10. F. Lammert, G. Wilkens, C.G. Dietrich, A. Geier, HE Wasmuth, S Matern: Extrahepatische
Manifestationen chronischer Lebererkrankungen. Versicherungsmedizin 2005 (57): 64-71.
11. A. Geier, G. Zollner, C.G. Dietrich: Ernährungsintervention bei Leber- und Gallenerkrankungen. Ernährung und Medizin, 2006, 21 (S1): 16-19.
12. C.G. Dietrich, A. Geier: Essen ist (un)gesund!? – Was wissen wir über
Nahrungsmittelkarzinogene? Ernährung und Medizin, 2006, 21 (S1): 12-16.
13. A. Geier, P. Fickert, M. Trauner: Mechanisms and clinical implications of cholestasis in
sepsis. Nature Clin Pract Gastroenterology&Hepatology 2006, 3(10): 574-85. IF 4,6
14. A. Geier, H. Deppe, S. Willis, R. Holy, C. Trautwein, C. Gartung: Interdisziplinäre Behandlung des Rektumkarzinoms. Deutsche Med. Wochenschrift 2006, 131(36):1945-50. IF 0,7
15. A. Geier, M. Wagner, C.G. Dietrich, M. Trauner: Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochem Biophys Acta 2007, 1773: 283-308.
IF 4,2
16. A. Geier, C. Trautwein: Bile acids are „homeotrophic“ sensors of the functional hepatic capacity and regulate adaptive growth during liver regeneration. Hepatology 2007, 45 (1):251-3. IF 9,8
17. J.J.W. Tischendorf, A. Geier, C. Trautwein: Current diagnosis and management of primary sclerosing cholangitis. Liver Transplant 2008, 14 (6): 735-46. IF 4,6
18. J. C. Mertens, A. Geier, B. Müllhaupt: Treatment of chronic hepatitis B and C -2010/Update
Praxis 2010, 99(17): 1015-28.
19. A. Geier: Shedding new light on vitamin D and fatty liver disease [Invited Editorial]. J Hepatology 2011, 55(2):273-5. IF 7,8
20. B. Stieger, A. Geier. Genetic Transporter Variations as Predisposing Factors for Drug Induced Cholestasis, Intrahepatic Cholestais of Pregnancy and Therapeutic Response of Viral Hepatitis. Expert Opinion on Drug Metabolism and Toxicology 2011, 7(4): 411-25.
21. P. Frei, A. Geier, P. Dutkowski, B. Müllhaupt. Neues aus der Hepatologie – Lebertransplantation. Therapeutische Umschau 2011, 68(4):219-24.
22. P. Samaras, A. Geier, O. Riesterer, P. Dutkowski. Tumore des biliären Trakts. Häufigkeit, Diagnostik und Therapie. Schweizerische Zeitschrift für Onkologie 2011 2: 26-31.
23. P.D. Greig, A. Geier, A.M. D’Alessandro, M. Campbell, L. Wright. Should we use deceased
LT after transplant failure from a LDLT? Liver Transplantation 2011 Suppl 2:S139-46. IF 4,6
24. F. Stickel, B. Helbling, M. Heim, A. Geier, C. Hirschi, B. Terziroli, K. Wehr, A. De Gottardi, F.
Negro, T. Gerlach. Critical review of the use of erythropoietin in the treatment of anaemia
during therapy for chronic hepatitis C. J Viral Hepatitis 2011, in press. IF 3,3
25. P.A. Clavien, M. Lesurtel, P.M. Bossuyt, G.J. Gores, B. Langer, A. Perrier (+ 110 Collaborators: … A. Geier, …); OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012 Jan;13(1):e11-22. IF 17,8
26. Swiss Association for the Study of the Liver (Collaborators: Moradpour D, Helbling B, Cerny A, De Gottardi A, Heim MH, Majno P, Müllhaupt B, Negro F, Rubbia-Brandt L, Semela D, Vilei SB, Bernsmeier C, Bihl F, Borovicka J, Dill M, Dufour JF, Filipowicz M, Geier A, Gerlach T, Giostra E, Gonvers JJ, Goossens N, Gubler C, Hadengue A, Heim MH, Helbling B, Hellstern M, Hirschi C, Jochum W, Krähenbühl S, Kullak-Ublick G, Lange C, Lavanchy D, Majno P, Malinverni R, McLin V, Mentha G, Mertens JC, Nasser S, Oneta C, Pache I, Rubbia-Brandt L, Sauter B, Semela D, Spahr L, Steuerwald M, Stickel F, Stieger B, Wehr K, Zala G). Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir. Swiss Med Wkly. 2012 Feb 24;142:w13516. doi: 10.4414/smw.2012.13516. IF 1,8
27. A. Geier, E. Schadde, B. Müllhaupt: Hepatozellulären Karzinom – Früherkennung, Staging und aktuelle Therapie. MMW Fortschr Med 2012, 154(13): 63-7.
28. M. Rau, K. Baur, A. Geier. Host Genetic Variants in the Pathogenesis of Hepatitis C. Viruses 2012; 4, 3281-3302. IF 1,5
C. Andere Publikationen
Fallberichte
1. E. Laubach, G. Meyer, P. Schwandt, T. Helmberger, A. Geier, K. Jacob, M.M. Ritter: Aldosteron-produzierendes Adenom der linken Nebenniere. Münch Med Wochenschr 1998, 140: 424-428. IF 0,2
2. A. Geier, H. Fürst, E. Laubach, A. Stäbler, R. Tiling, J. Müller-Höcker, P. Schwandt, M.M. Ritter: Somnolenz und Erbrechen bei einer Patientin nach operiertem Nebenschilddrüsen-Carcinom. Internist 1999, 40: 311-315. IF 0,4
3. A. Geier, F. Lammert, C. Gartung, H.N. Nguyen, S. Matern: MRCP imaging for diagnosis and pre-interventional evaluation of fluid thoracic mass. Eur J Gastroenterol Hepatol 2003, 15: 429-431. IF 1,8
4. A. Geier, C. Gartung, C.G. Dietrich, H.E. Wasmuth, P. Reinartz, S. Matern: Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient with complicating hepatocellular carcinoma. World J Gastroenterol 2003, 9: 2681-2685. IF 3,3
5. E. Siewert, L. Tietze, C. Maintz, A. Geier, C.G. Dietrich, S. Matern, C. Gartung: Gastrointestinale Stromatumoren (GIST): variable klinische Manifestationen vom Zufallsbefund bis zur akuten gastrointestinalen Blutung. Z Gastroenterologie 2004, 42: 233-42. IF 1,0
6. E. Siewert, A. Geier, C.G. Dietrich, B. Backes, S. Matern, C. Gartung: Akutes Mononukleose-ähnliches Krankheitsbild bei Primär- und Reinfektiobn mit dem Cytomegalievirus. Medizinische Klinik 2004, 99: 154-61. IF 0,5
7. C.G. Dietrich, C. Gartung, J. Lorenzen, A. Geier, H.E. Wasmuth, S. Matern, F. Lammert: Enlarged cervical lymph nodes and elevated liver chemistry tests: a therapeutic dilemma. Ann Hepatology 2004, 3: 118-20.
8. E. Siewert, W. Weyers, C.G. Dietrich, A. Geier, F. Lammert, S. Matern: Cutaneous
mucinosis and skin necrosis complicates interferon alfacon-1 (consensus interferon)
treatment of chronic hepatitis C. Eur J Med Res 2005, 10: 63-7. IF 0,9
9. A. Geier, C. Gartung, I. Theurl, G. Weiss, F. Lammert, C.G. Dietrich, R. Weiskirchen, H. Zoller, B. Hermanns, S. Matern: Occult celiac disease prevents the penetrance of hemochromatosis. World J Gastroenterol 2005, 11 (21): 3323-6. IF 3,3
10. C.G. Dietrich, C. Gartung, E. Siewert, F. Lammert, S. Matern, A. Geier: Therapierefraktäre schwere pulmonal-arterielle Hypertonie nach Lebertransplantation bei HCV-Leberzirrhose. Z Gastroenterologie 2006, 44 (1): 3-7. IF 0,8
11. A. Geier, A. Koch, J. Bach, W. Schäfer, M. Jansen, C. Trautwein: Profuse rectal bleeding of no visible cause. Lancet 2007, 369 (9573): 1664. IF 23,9
12. L.E. Sander, A. Koch, C. Gartung, A. Donner, R. Winograd, A. Wellmann, C. Trautwein, A. Geier: Lessons from an unusual hepatic overlap syndrome.
Nature Clin Pract Gastroenterology&Hepatology 2007, 4 (11): 635-40.
13. H.H. Lutz, M. Spannbauer, A. Koch, A. Donner, B. Heintz, C. Trautwein, A. Geier: Systemischer Lupus erythematodes als Begleiterkrankung einer refraktären Autoimmunhepatitis; Behandlung mit Mycophenolatmofetil. Gastroenterologie Up2date 2008, 4 (1): 6-11.
14. J.C. Mertens, A. Weber, B. Müllhaupt, A. Geier: Unusual cause of biliary colic in a Swiss farmer. Liver International 2011, 31(5): 666. IF 3,0.
15. P. Frei, A. Weber, A. Geier, J.C. Mertens, M. Fried, G. Rogler, B. Müllhaupt: Lessons from a transplant patient with diarrhea, cryptosporidial infection and possible mycophenolate mofetil-associated colitis. Transpl Infect Dis 2011, 13(4):416-8. IF 2,1.
16. P. Frei, E.I. Minder, N. Corti, B. Muellhaupt, A. Geier, H. Adams, J.P. Dutertre, A. Rudiger, P. Dutkowski, M. Maggiorini, C.C. Ganter. Liver Transplantation because of Acute Liver Failure due to Heme Arginate Overdose in a Patient with Acute Intermittent Porphyria. Case Rep Gastroenterol. 2012; 6(1):190-6.
Korrespondenz
17. T.M. Berghaus, A. Baron, A. Geier, P. Conzen, R. Lamerz, G. Paumgartner: Hepatotoxicity following Desflurane Anesthesia. Hepatology 1999, 29: 613-614. IF 8,0
18. A. Geier, H.N. Nguyen, C. Gartung, S. Matern: MRCP versus ERCP in the detection of small ampullary carcinoma. Lancet 2000, 356: 1607-1608. IF 13,3
19. H.E. Wasmuth, C. Stolte, A. Geier, C. Gartung, S. Matern: Induction of multiple autoantibodies to islet cell antigens during treatment with interferon alpha for chronic hepatitis C. Gut 2001, 49: 595-600. IF 6,2
20. C.G. Dietrich, A. Geier, S. Matern, C. Gartung: Multidrug resistance and response to antiretroviral treatment. Lancet 2002, 359: 2114-2115. IF 18,3
21. C.G. Dietrich, A. Geier, F. Lammert: Bosentan for pulmonary hypertension. New Engl J Med 2002, 347: 292-294. IF 31,7
22. A. Geier, C. Gartung: Diskussion: Moderne Diagnostik benigner und maligner Raumforderungen der Leber. Dt Ärzteblatt 2002, 99 (33): A 2206.
23. A. Geier, C. Gartung, C.G. Dietrich: Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002, 347: 1721-1722. IF 31,7
24. A. Geier, C.G. Dietrich, C. Gartung: Antiviral Therapy in HBe-Ag-positive Hepatitis B with normal aminotransferase levels. Hepatology 2003, 37: 712-713. IF 9,5
25. C.G. Dietrich, A. Geier: It takes more than one–is a single UGT polymorphism enough to bother detoxification? Hepatology 2005, 42 (6): 1462. IF 9,8
26. C.G. Dietrich, C. Gartung, F. Lammert, A. Geier: Portopulmonale Hypertonie nach Lebertransplantation. Z Gastroenterologie 2006, 44 (4) 348. IF 0,8
Buchbeiträge
1. A. Geier, S. Matern, C. Gartung. Regulation of sinusoidal bile acid transporters in cholestasis and during liver regeneration. In: Boyer, J.L., Keppler, D., Matern, S., Meier-Abt, P.J. eds. Hepatobiliary Transport: From Bench to Bedside. Dordrecht, Boston, London: Kluwer Academic Publishers 2001, 32-36.
2. A. Geier, S. Matern, C. Gartung. Regulation of hepatocellular organic anion transporters by cytokines. In: Gressner, A.M., Heinrich, P.C., Matern, S. eds. Cytokines in Liver Injury and Repair. Dordrecht, Boston, London: Kluwer Academic Publishers 2002, 201-204.
3. A. Geier, C. Trautwein. Leberzelluntergang und -regeneration. In: Riemann, Fischbach,
Galle, Mössner: Gastroenterologie in Klinik und Praxis. Thieme Verlag 2007, 1237-46.
4. I.V. Martin, A. Geier. Reactivation of hepatic organic anion transporters in different forms of acquired cholestasis by nuclear hormone receptor activators. In: Jansen, P.L.M., Keppler, D., Beuers, U., Stiehl, A., Trauner, M. eds. Bile Acid Biology and Therapeutic Actions. Dordrecht, Boston, London: Kluwer Academic Publishers 2009, 185-191.
5. A. Geier, B. Müllhaupt: Monitoring the patient awaiting liver transplantation. In: Killenberg, PG, Clavien, PA, eds. Medical Care of the Liver Transplant Patient 4th Edition, Wiley-Blackwell 2012, in Press.
6. A. Geier, B. Müllhaupt: Sexual function and fertility after liver transplantation. In: Killenberg, PG, Clavien, PA, eds. Medical Care of the Liver Transplant Patient 4th Edition, Wiley-Blackwell 2012, in Press.
